PFS
CRL icon

Prospera Financial Services’s Charles River Laboratories CRL Stock Holding History

Prospera Financial Services’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,809
Closed -$312K – 1481
2026
Q1 		$312K Sell
1,809
-107
-6% -$19.8K 0.01% 1190
2025
Q4 		$382K Buy
+1,916
New +$348K 0.01% 1037
2023
Q3 		– Sell
-975
Closed -$205K – 1016
2023
Q2 		$205K Buy
+975
New +$194K 0.01% 945
2023
Q1 		– Sell
-960
Closed -$209K – 965
2022
Q4 		$209K Buy
+960
New +$210K 0.01% 831
2022
Q3 		– Sell
-772
Closed -$165K – 994
2022
Q2 		$165K Sell
772
-167
-18% -$40.8K 0.01% 781
2022
Q1 		$267K Buy
+939
New +$290K 0.01% 780

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Prospera Financial Services's CRL Position: Q2 2026 in Review

Prospera Financial Services sold out of Charles River Laboratories (CRL) in Q2 2026, closing a stake of 1,809 shares — an estimated $312K sold.

Prospera Financial Services first reported a position in CRL in Q1 2022 and held it in 6 quarters. The position peaked at $382K in Q4 2025. 563 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Prospera Financial Services reported no remaining Charles River Laboratories position as of Q2 2026 after selling out during the quarter.
  • Prospera Financial Services sold 1,809 Charles River Laboratories shares in Q2 2026, an estimated $312K.
  • Prospera Financial Services first reported a position in Charles River Laboratories in Q1 2022 and held it in 6 quarters.
  • Prospera Financial Services's Charles River Laboratories position peaked at $382K in Q4 2025.
  • 563 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Prospera Financial Services's 13F filing for Q2 2026, filed 15 Jul 2026.